We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Illustration

AI Model for Early Detection of SARS-CoV2 in Children Could Pave Way for Rapid Bedside COVID-19 Diagnostic Device

An artificial intelligence (AI) model to aid in the early detection of severe SARS-CoV2 illness in children is expected to improve outcomes via early recognition, timely intervention and appropriate allocation of critical resources, as well as lead to the development of a rapid bedside COVID-19 diagnostic device. More...
05 Feb 2021
Image: BD Multitest 6-Color TBNK Reagent with BD Trucount Tubes (Photo courtesy of Becton, Dickinson and Company)

Becton Dickinson Launches Assay for Determining COVID-19 Patients’ Risk of IMV and Mortality at Hospitalization

Becton, Dickinson and Company (BD Franklin Lakes, NJ, USA) has announced the CE mark of BD Multitest 6-Color TBNK Reagent with BD Trucount Tubes with expanded clinical application to help clinicians identify COVID-19 patients at increased relative risk of intubation with mechanical ventilation (IMV) and mortality at hospital admission, in conjunction with clinical findings and the results of other laboratory testing. More...
05 Feb 2021
Image: Pioneering Automated COVID-19 Test Robot Can Process 20,000 Samples for SARS-CoV-2 Testing Per 24 Hours (Photo courtesy of Hubrecht Institute)

Pioneering Automated COVID-19 Test Robot Can Process 20,000 Samples for SARS-CoV-2 Testing Per 24 Hours

A new COVID-19 test robot can process up to 20,000 samples for SARS-CoV-2 testing per 24 hours, making it much faster than all other systems used to date. More...
04 Feb 2021
Image: 10-Minute COVID-19 Diagnostic Test Based on Nanoparticles Identifies IgG Antibodies and Costs Only Fifth of Market Average (Photo courtesy of Karla Castro/USP)

10-Minute COVID-19 Diagnostic Test Based on Nanoparticles Identifies IgG Antibodies and Costs Only Fifth of Market Average

A new COVID-19 test uses technology based on nanoparticles to detect antibodies to the novel coronavirus in 10 minutes and costs only a fifth of the market average. More...
04 Feb 2021
Illustration

Ground-Breaking Study Finds Plant-Derived Antiviral to Be Effective Against COVID-19

Researchers have discovered a novel antiviral property of a drug that could have major implications in how future epidemics/pandemics - including COVID-19 - are managed. More...
04 Feb 2021
Illustration

COVID-19 Pneumonia Treated with Ultra-Low Doses of Radiotherapy in ULTRA-COVID Study

Radiotherapy could play a role in reducing the inflammatory response in lungs and relieve life-threatening symptoms of COVID-19 patients, according to a new study. More...
04 Feb 2021
Image: The computer model can predict how human genes and medicines will interact (Photo courtesy of Getty Images)

Deep-Learning Model that Can Predict How Human Genes and Medicines Will Interact Identifies Promising COVID-19 Treatments

A new deep-learning model that can predict how human genes and medicines will interact has identified at least 10 compounds that may hold promise as treatments for COVID-19. More...
03 Feb 2021
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Hospital Data Analytics Software
OR Companion
New
Digital Radiographic System
OMNERA 300M
Copyright © 2000-2024 Globetech Media. All rights reserved.